Abrdn Life Sciences Investors

(NYSE) HQL

Current Price$17.80

Market Cap$553.43M

Since IPO (1992)+2,044%

5 Year+57%

1 Year+67%

1 Month-0%

Abrdn Life Sciences Investors Financials at a Glance

Market Cap

$553.43M

Revenue (TTM)

$33.81M

Net Income (TTM)

$170.89M

EPS (TTM)

$2.89

P/E Ratio

6.29

Dividend

$1.91

Beta (Volatility)

0.75 (Low)

Dividend

$1.91

Beta (Volatility)

0.75 (Low)

Price

$17.80

Volume

83,480

Open

$18.19

Price

$17.80

Volume

83,480

Open

$18.19

Previous Close

$17.78

Daily Range

$17.77 - $18.23

52-Week Range

$12.12 - $18.46

Dividend

$1.91

Beta (Volatility)

0.75 (Low)

Price

$17.80

Volume

83,480

Open

$18.19

Previous Close

$17.78

Daily Range

$17.77 - $18.23

52-Week Range

$12.12 - $18.46

HQL News

The Best ETF for 2007: H&Q Life Sciences Investors

Jim FinkNov 16, 2006

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abrdn Life Sciences Investors

Industry

Capital Markets

Sector

Financials

Website

www.teklacap.com/hql.html

Headquarters

Philadelphia, MA 02110, US

HQL Financials

Key Financial Metrics (TTM)

Gross Margin

31%

Operating Margin

Net Income Margin

Return on Equity

18%

Return on Capital

17%

Return on Assets

17%

Earnings Yield

15.90%

Dividend Yield

10.49%

Payout Ratio

36.96%

Stock Overview

Market Cap

$553.43M

Shares Outstanding

30.41M

Volume

83.48K

Avg. Volume

109.86K

Financials (TTM)

Gross Profit

$86.39M

Operating Income

$85.59M

EBITDA

$85.59M

Operating Cash Flow

$2.32M

Capital Expenditure

$5.00

Free Cash Flow

$2.32M

Cash & ST Invst.

$75.54K

Total Debt

$0.00

Abrdn Life Sciences Investors Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$11.63M

-60.6%

Gross Profit

$9.19M

-65.9%

Gross Margin

78.99%

N/A

Market Cap

$553.43M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$132.83M

+1260.0%

EBITDA

$132.83M

+1260.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$75.54K

-99.5%

Accounts Receivable

$1.14M

-77.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

16.61%

N/A

Return on Invested Capital

16.63%

N/A

Free Cash Flow

$1.28M

N/A

Operating Cash Flow

$1.28M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ECCEagle Point Credit Company Inc.

ECCEagle Point Credit Company Inc.$4.03-1.10%

GAINGladstone Investment Corporation

GAINGladstone Investment Corporation$16.41-1.03%

GLADGladstone Capital Corporation

GLADGladstone Capital Corporation$19.21-0.72%

CCAPCrescent Capital BDC, Inc.

CCAPCrescent Capital BDC, Inc.$11.13-7.17%

SORSource Capital, Inc.

SORSource Capital, Inc.$45.38-0.73%

MCIBarings Corporate Investors

MCIBarings Corporate Investors$17.21-0.64%

TCPCBlackRock TCP Capital Corp.

TCPCBlackRock TCP Capital Corp.$4.15-3.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About HQL

What is the current price of Abrdn Life Sciences Investors?

Abrdn Life Sciences Investors is trading at $17.78 per share.

What is the 52-week range for Abrdn Life Sciences Investors?

Over the past 52 weeks, Abrdn Life Sciences Investors has traded between $12.12 and $18.46.

How much debt does Abrdn Life Sciences Investors have?

As of the most recent reporting period, Abrdn Life Sciences Investors reported total debt of N/A.

How much cash does Abrdn Life Sciences Investors have on hand?

Abrdn Life Sciences Investors reported $75,538 in cash and cash equivalents in its most recent financial results.

What is Abrdn Life Sciences Investors’s dividend yield?

Abrdn Life Sciences Investors currently has a dividend yield of 10.49%.

Abrdn Life Sciences Investors

Abrdn Life Sciences Investors Financials at a Glance

HQL News

The Best ETF for 2007: H&Q Life Sciences Investors

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Abrdn Life Sciences Investors

HQL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Abrdn Life Sciences Investors Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HQL

What is the current price of Abrdn Life Sciences Investors?

What is the 52-week range for Abrdn Life Sciences Investors?

How much debt does Abrdn Life Sciences Investors have?

How much cash does Abrdn Life Sciences Investors have on hand?

What is Abrdn Life Sciences Investors’s dividend yield?

Premium Investing Services